Cannabis in Greece

Cannabis in Greece

Greece has been historically a small cannabis market comprised of an overwhelming share of illicit value sales and a small percentage of CBD sales, whereas medical and adult-use cannabis products were not allowed. Despite scope being rather limited in 2024, the introduction of medical cannabis in Greece is a step forward and might open the door to further regulatory changes in line with other European cannabis markets over the next decade.

Euromonitor International's Cannabis in Greece market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.